Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin in Autism
NCT00065962Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 1999
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of secretin in Autism Spectrum Disorder (ASD), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jun 1999; status: completed.
02
Drugs
secretin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00065962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065962.